• Merck to establish $1.3bn research hub in London pharmaceutical-technology
    August 20, 2020
    US-based pharmaceutical company Merck, known as MSD in Europe, is set to build a $1.3bn (£1bn) research hub on a 25,000m2 site in London, England, UK.
PharmaSources Customer Service